Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Mesa Laboratories (MLAB) EBITDA (2016 - 2025)

Mesa Laboratories' EBITDA history spans 16 years, with the latest figure at $8.0 million for Q4 2025.

  • On a quarterly basis, EBITDA rose 38.0% to $8.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $2.1 million, a 100.84% increase, with the full-year FY2025 number at $1.3 million, up 100.46% from a year prior.
  • EBITDA hit $8.0 million in Q4 2025 for Mesa Laboratories, up from $4.7 million in the prior quarter.
  • Over the last five years, EBITDA for MLAB hit a ceiling of $8.0 million in Q4 2025 and a floor of -$271.3 million in Q1 2024.
  • Historically, EBITDA has averaged -$12.5 million across 5 years, with a median of $3.1 million in 2021.
  • Biggest five-year swings in EBITDA: crashed 11518.18% in 2021 and later skyrocketed 8725.37% in 2024.
  • Tracing MLAB's EBITDA over 5 years: stood at -$2.5 million in 2021, then skyrocketed by 235.43% to $3.4 million in 2022, then tumbled by 101.97% to -$67000.0 in 2023, then skyrocketed by 8725.37% to $5.8 million in 2024, then soared by 38.0% to $8.0 million in 2025.
  • Business Quant data shows EBITDA for MLAB at $8.0 million in Q4 2025, $4.7 million in Q3 2025, and $3.1 million in Q2 2025.